Skip to main content

Table 2 An overview of typical concentrations of toxic organic compounds reported in non-invasive human matrices (arithmetic mean (rangea))

From: Applicability of non-invasively collected matrices for human biomonitoring

 

Hexachlorobenzene (HCB)

(ng/g lipid)

PCDD/F

(in pg TEQ/g lipid)

Cotinine

(in non-smokers)

Urine

(μg/l)

PCP: 3.8 (0.6–18.0)c

PCBT: 8.8 (0.5–86.9)c

[57]

-

17.9 (ND-3400)

[37]

Urine

(μg/g creatinine)

-

-

17.1 (ND-5810)

[37]

Placenta

(ng/g wet weight)

7.7b (2.2–26.5)

[49]

31 (10–74)

[47]

-

Cord blood

(μg/l)

0.73 (0.14–9.82)

[50]

14 (3.7–32)

[47]

3.08 (ND-910)

[51]

Exhaled breath (μg/l)

-

-

21 (ND-42)e

[59]

Breast milk

(ng/g lipid)

12.4 (6.01–24.56)

[49]

9.5 (2.7–51.5)

[52]

0.2 (0.03–1.3)

[53]

Hair

(μg/g)

28 (20–32)d

[89]

- (0.25–230)

[26]

0.29 (ND-11)

[45]

  1. a Range may include high levels at which adverse effects are expected; b Arithmetic mean (P10-P95); c Metabolites of HCB, expressed in μg/24 h; d Median (P25-P75); e Cotinine in saliva; f ND: below detection limit